Endogena is a clinical-stage biotechnology company that discovers and develops first-in-class endogenous regenerative medicines to repair diseased tissues. Our unique approach has the potential for a paradigm shift in how degenerative conditions due to aging and genetic disorders are treated.

Products, services, technology

Endogena Therapeutics’ novel drug discovery approach is based on the concept of leveraging artificial intelligence to identify small molecules that can selectively re-activate dormant endogenous stem- or progenitor cells, allowing them to initiate a natural local tissue repair process.

Cooperation possibilities

Partnering, scientific collaborations, funding

Some insights
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in